Company intelligence / Profile preview

Embark Veterinary

Boston, Massachusetts, United Statesembarkvet.com ↗

Ownership: Private
Employees: ~110
Development stage: Commercial

Overview

Embark has tested over one million dog samples. Its DNA tests provide breed identification with high accuracy (>99%), screen for more than 270 inherited diseases, analyze over fifty physical traits, and offer actionable insights into canine wellness. The company’s research has contributed to the largest canine genetic mapping studies to date. There are no clinical trials as it does not develop therapeutics.

Therapeutic areas: OtherRare DiseasesGastroenterology
Modalities: Genetic testing (DNA analysis)Microbiome testing (for gut health)Nutritional supplements (for dogs)
Industry: Molecular Diagnostics

Partnerships

Cornell University College of Veterinary Medicine—major academic/research partner.

Beyond the preview

Go deeper on Embark Veterinary.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Embark Veterinary.

Explore the full profile